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Abstract	  Microglia,	  the	  immune	  cells	  of	  the	  brain,	  have	  traditionally	  been	  studied	  solely	  for	  their	  immunological	  functions.	  Here,	  we	  suggest	  a	  novel	  involvement	  of	  microglia	  in	  the	  development	  and	  maintenance	  of	  addiction	  to	  opioids	  and	  other	  drugs	  of	  abuse.	  In	  response	  to	  drugs	  of	  abuse	  such	  as	  morphine,	  microglia	  shift	  to	  an	  activated	  state	  that	  involves	  upregulated	  release	  of	  cytokines	  and	  chemokines,	  the	  small	  cell-­‐signaling	  protein	  molecules	  of	  the	  immune	  system.	  Previous	  work	  in	  our	  laboratory	  has	  demonstrated	  that	  increased	  expression	  of	  the	  anti-­‐inflammatory	  cytokine,	  IL-­‐10,	  inhibits	  morphine-­‐induced	  glial	  pro-­‐inflammation	  within	  the	  nucleus	  accumbens	  (NAcc),	  and	  prevents	  morphine	  relapse.	  We	  therefore	  seek	  to	  translate	  these	  findings	  to	  a	  mouse	  model	  in	  order	  to	  further	  our	  research	  through	  transgenic	  manipulations.	  Through	  this	  project,	  we	  verify	  the	  viability	  of	  a	  mouse	  model	  through	  the	  elucidation	  of	  the	  molecular	  response	  to	  morphine	  administration	  in	  mice.	  We	  identify	  the	  optimal	  time	  point	  (e.g.	  60	  minutes)	  for	  identifying	  the	  molecular	  profile	  of	  morphine	  administration	  due	  to	  optimal	  morphine	  activity.	  Additionally,	  important	  patterns	  of	  cytokine	  expression	  observed	  in	  rat	  studies	  involving	  toll-­‐like-­‐receptor	  (TLR)4,	  CCL4,	  and	  neuronal	  fractalkine,	  are	  reproduced	  in	  mice.	  TLR4	  has	  been	  implicated	  as	  a	  major	  player	  in	  addiction;	  therefore,	  we	  also	  tested	  the	  learning	  and	  memory	  abilities	  of	  a	  TLR4	  knockout	  (KO)	  mouse	  through	  the	  well-­‐established	  fear-­‐conditioning	  paradigm	  since	  addiction	  is	  closely	  related	  to	  cognition.	  TLR4	  KO	  behavior	  analysis	  shows	  no	  significant	  difference	  in	  fear	  conditioning	  between	  male	  TLR4	  heterozygote	  (HET)	  and	  KO	  mice.	  Densitometry	  analysis	  also	  shows	  no	  difference	  in	  microglia	  density	  in	  these	  animals.	  Collectively,	  these	  results	  confirm	  the	  viability	  of	  a	  mouse	  model	  in	  continuing	  our	  research,	  investigating	  the	  role	  of	  microglia	  in	  addiction.	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Introduction	  The	  neural	  mechanisms	  of	  addiction,	  despite	  being	  a	  major	  socioeconomic	  burden	  and	  a	  topic	  of	  vast	  research,	  remain	  poorly	  understood.	  Microglia,	  the	  immune	  cells	  of	  the	  brain,	  have	  traditionally	  been	  studied	  for	  their	  immunological	  functions	  such	  as	  destroying	  invading	  microorganisms,	  scavenging	  for	  harmful	  debris,	  and	  acting	  as	  antigen-­‐presenting	  cells	  that	  activate	  T-­‐cells,	  in	  order	  to	  regain	  homeostasis	  [1].	  	  However,	  recent	  literature	  has	  shown	  increasing	  evidence	  that	  glial	  cells	  play	  an	  important	  role	  in	  mediating	  addiction.	  A	  majority	  of	  addiction	  research	  has	  focused	  primarily	  on	  the	  neuronal	  mechanisms	  of	  addiction,	  but	  here,	  we	  present	  the	  novel	  involvement	  of	  microglia	  in	  the	  development	  and	  maintenance	  of	  addiction.	  Previous	  work	  in	  our	  laboratory	  demonstrates	  that	  microglial	  activation,	  brought	  on	  by	  drug	  use,	  may	  play	  a	  role	  in	  mediating	  addiction.	  We	  seek	  to	  further	  this	  research,	  originally	  done	  in	  rats,	  by	  translating	  this	  work	  to	  a	  mouse	  model	  in	  order	  to	  capitalize	  on	  the	  opportunity	  for	  transgenic	  manipulation.	  This	  work	  is	  increasingly	  important	  because	  the	  elucidation	  of	  the	  neuronal	  mechanisms	  of	  addiction	  may	  aid	  us	  in	  identifying	  liability	  and	  preventing	  addiction	  risk	  and	  relapse.	  The	  word	  ‘glia’	  is	  an	  encompassing	  term	  for	  the	  primary	  immunocompetent	  cells	  of	  the	  CNS	  that	  includes	  microglia	  and	  astrocytes	  [2].	  Microglia	  are	  a	  specialized	  subset	  of	  macrophages	  in	  the	  CNS	  that	  actively	  scan	  tissue	  for	  damage,	  which	  challenges	  the	  traditional	  notion	  of	  quiescent	  microglia	  in	  the	  healthy	  brain	  [3].	  In	  response	  to	  an	  immune	  challenge,	  microglia	  are	  activated	  by	  cytokines	  produced	  by	  nearby	  immune	  effector	  cells,	  such	  as	  T-­‐cells,	  or	  by	  surface	  structures	  and	  DNA/RNA	  of	  viral,	  bacterial,	  or	  fungal	  origin	  such	  as	  bacterial	  lipopolysaccharide	  (LPS)	  among	  other	  triggers	  [3].	  This	  activation	  may	  be	  better	  described	  as	  a	  change	  in	  phenotype	  rather	  than	  a	  general	  awakening	  because	  of	  the	  continual	  screening	  activity	  that	  takes	  place	  in	  the	  normal	  brain	  [3].	  Glia	  are	  activated	  by	  drugs	  of	  abuse,	  such	  as	  morphine,	  and	  this	  activation	  leads	  to	  a	  multitude	  of	  effects	  such	  as	  altered	  neuronal	  excitability	  and	  synaptic	  connectivity,	  as	  well	  as	  reduced	  opioid-­‐induced	  analgesia	  and	  increased	  opioid	  tolerance	  [4-­‐6].	  Glial	  cells	  generally	  act	  through	  triggering	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intracellular	  cascades	  that	  result	  in	  plastic	  changes	  to	  the	  CNS,	  and	  because	  astrocytes	  and	  microglia	  can	  encapsulate	  synapses,	  they	  are	  in	  a	  unique	  position	  to	  modulate	  synaptic	  transmission	  [7].	  	  Regardless	  of	  the	  specific	  mechanism	  through	  which	  opioids	  induce	  glial	  activation,	  it	  is	  important	  to	  acknowledge	  the	  role	  glial	  activation	  plays	  in	  the	  mediation	  of	  pain	  signaling	  and	  the	  great	  need	  to	  separate	  the	  mechanisms	  that	  contribute	  to	  the	  beneficial	  and	  detrimental	  actions	  of	  opioids.	  Understanding	  glial	  activation	  during	  opiate	  exposure	  and	  glial	  activity	  in	  relation	  to	  addiction	  development	  is	  significant	  because	  of	  the	  potential	  to	  create	  novel	  treatments	  that	  may	  increase	  analgesia	  while	  avoiding	  addiction,	  tolerance,	  or	  withdrawal	  symptoms	  after	  use.	  Elucidated	  pathways	  serve	  as	  potential	  targets	  for	  pharmaceutical	  intervention	  that	  may	  decrease	  the	  widespread	  socioeconomic	  impact	  of	  drug	  abuse	  by	  lessening	  the	  compulsion	  of	  addiction,	  reducing	  the	  risk	  of	  relapse,	  and	  identifying	  those	  individuals	  who	  are	  vulnerable	  to	  drug	  abuse.	  	  
Societal	  and	  health	  consequences	  of	  drug	  addiction	  Drug	  addiction	  poses	  a	  large	  threat	  to	  the	  economic	  and	  health	  status	  of	  countries	  around	  the	  world.	  The	  insidious	  nature	  of	  drug	  use	  stems	  from	  the	  fact	  that	  addicts	  compulsively	  use	  drugs	  even	  when	  they	  are	  aware	  of	  the	  negative	  consequences,	  and	  they	  are	  vulnerable	  to	  episodes	  of	  relapse	  characterized	  by	  uncontrollable	  drug-­‐seeking	  behaviors.	  Nearly	  two	  decades	  ago,	  the	  cost	  of	  drug	  abuse	  in	  the	  United	  States	  was	  estimated	  to	  be	  around	  114.2	  billion	  dollars,	  and	  this	  figure	  is	  projected	  to	  have	  increased	  significantly	  due	  to	  inflation	  and	  population	  growth	  [8].	  Few	  substances	  throughout	  medical	  history	  have	  had	  such	  widespread	  and	  prolonged	  use	  as	  opioids,	  which	  are	  derived	  from	  the	  dried	  sap	  of	  the	  Papaver	  somniferum,	  or	  poppy	  plant	  [9].	  Opiate	  drugs	  are	  those	  drugs	  classified	  by	  their	  ability	  to	  bind	  opioid	  receptors,	  and	  this	  family	  of	  drugs	  includes	  some	  of	  the	  most	  widely	  used	  analgesics	  in	  the	  U.S.,	  such	  as	  hydrocodone	  (Vicodin),	  codeine,	  and	  morphine.	  Morphine,	  the	  first	  active	  alkaloid	  isolated	  from	  the	  opium	  poppy,	  is	  so	  potent	  an	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analgesic	  that	  it	  is	  considered	  the	  ‘gold	  standard’	  for	  opioid	  analgesics	  [9].	  However,	  due	  to	  its	  potency,	  morphine	  abuse	  has	  steadily	  increased	  in	  recent	  years,	  becoming	  the	  second	  most	  frequently	  abused	  illicit	  drug	  amongst	  secondary	  students	  in	  the	  United	  States	  [10].	  	  Another	  issue	  of	  concern	  in	  the	  healthcare	  sector	  is	  the	  development	  of	  addiction	  to	  prescribed	  drugs	  during	  therapy.	  	  From	  a	  pharmacological	  perspective,	  prescription	  drugs	  have	  the	  same	  molecular	  profile	  and	  mechanism	  of	  action	  as	  drugs	  of	  abuse.	  Several	  factors	  influence	  the	  potential	  risk	  for	  addiction	  such	  as	  dose,	  administration,	  context,	  and	  expectation.	  It	  is	  important	  to	  note	  that	  these	  risk	  factors	  apply	  to	  all	  forms	  of	  drug	  addiction	  and	  do	  not	  separate	  drug	  abusers	  from	  non-­‐drug	  abusers.	  For	  some	  drugs,	  such	  as	  methylphenidate	  used	  for	  attention	  deficit	  disorder,	  the	  prescribed	  dose	  is	  typically	  below	  the	  level	  expected	  to	  produce	  reinforcement	  [11].	  However,	  this	  is	  not	  always	  true,	  as	  seen	  in	  cases	  of	  opioid	  analgesics,	  where	  the	  dose	  for	  adequate	  pain	  control	  is	  similar	  to	  that	  used	  by	  abusers	  [12].	  In	  some	  instances,	  non-­‐abusers	  and	  abusers	  may	  react	  differently	  to	  the	  same	  dosage.	  For	  example,	  non-­‐abusers	  may	  feel	  non-­‐reinforcing	  symptoms	  such	  as	  discomfort	  while	  abusers	  experience	  highly	  reinforcing	  analgesia	  [12].	  This	  emphasizes	  the	  fact	  that	  drug	  tolerance,	  addiction,	  and	  pleasure	  are	  highly	  influenced	  by	  individual	  differences.	  In	  fact,	  opioid	  drug	  abuse	  has	  a	  high	  heritability	  rate	  and	  a	  family	  history	  of	  opioid	  abuse	  is	  one	  of	  the	  most	  potent	  risk	  factors	  for	  addiction	  [13].	  Studies	  comparing	  morphine	  effects	  on	  two	  strains	  of	  mice	  (C57BL/6J	  and	  DBA/2J)	  show	  that	  morphine	  administration	  has	  a	  differential	  effect	  based	  on	  genotype	  [13].	  Opioid	  use	  is	  foreseen	  to	  continue	  indefinitely	  because	  of	  its	  extensive	  use	  in	  areas	  such	  as	  surgery,	  palliative	  care,	  and	  chronic	  pain	  management;	  therefore,	  it	  is	  important	  to	  continue	  investigating	  the	  mechanisms	  through	  which	  opioids	  act	  in	  order	  to	  define	  the	  factors	  that	  contribute	  to	  addiction	  and	  relapse	  liability.	  In	  light	  of	  these	  findings,	  much	  research	  over	  the	  past	  decade	  has	  sought	  to	  elucidate	  the	  neural	  pathway	  of	  addiction.	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Neural	  substrates	  of	  addiction	  The	  first	  step	  towards	  this	  goal	  is	  to	  identify	  which	  specific	  neural	  substrates	  are	  involved	  with	  drug	  reward	  in	  order	  to	  better	  understand	  the	  neural	  pathway	  that	  supports	  drug	  addiction.	  Using	  Fos	  protein	  expression	  as	  a	  marker	  of	  neuronal	  activity,	  various	  brain	  nuclei	  have	  been	  studied	  in	  relation	  to	  cue-­‐induced	  opiate	  seeking	  [14].	  Structures	  activated	  in	  morphine-­‐seeking	  mice	  were	  the	  nucleus	  accumbens	  (NAcc)	  core,	  basolateral	  amygdala,	  substantia	  nigra	  pars	  reticulata	  (SNpr),	  and	  the	  central	  nucleus	  of	  the	  amygdala	  [14].	  All	  of	  these	  brain	  regions	  are	  associated	  with	  the	  well-­‐characterized	  reward	  pathway	  [14,	  15].	  Additionally,	  many	  studies	  have	  explored	  the	  role	  of	  the	  NAcc	  and	  substantia	  nigra	  pars	  compacta	  (SNpc)	  in	  addiction	  because	  of	  their	  roles	  in	  dopamine	  (DA)	  reward	  signaling.	  Activation	  of	  these	  specific	  areas	  supports	  a	  cortico-­‐striatal	  limbic	  circuit	  that	  may	  drive	  morphine	  seeking	  following	  a	  period	  of	  drug	  abstinence	  [14].	  However,	  studies	  must	  not	  be	  limited	  to	  the	  traditional	  neural	  structures	  associated	  with	  drug	  addiction	  because	  this	  limitation	  eliminates	  the	  possibility	  of	  finding	  novel	  brain	  regions	  that	  may	  play	  a	  role	  in	  addiction,	  maintenance,	  and	  extinction.	  Therefore,	  a	  wide	  range	  of	  brain	  regions	  has	  been	  tested	  in	  addition	  to	  these	  traditional	  circuits.	  Noteworthy	  substrates	  include	  the	  lateral	  hypothalamus,	  which	  may	  be	  involved	  in	  context-­‐induced	  reward	  seeking,	  the	  NAcc	  shell,	  which	  is	  associated	  with	  drug	  seeking	  behavior	  driven	  by	  spatial	  and	  contextual	  information,	  and	  the	  locus	  coeruleus,	  periaqueductal	  gray,	  and	  lateral	  habenula	  which	  are	  related	  to	  reward	  expectancy	  and	  incentive	  value	  [14].	  These	  preliminary	  studies	  have	  shown	  us	  that	  addiction	  pathways	  may	  not	  be	  as	  localized	  as	  we	  once	  thought	  and	  that	  continued	  research	  must	  be	  done	  in	  order	  to	  identify	  critical	  target	  areas.	  	  It	  has	  been	  suggested	  that	  neural	  adaptations	  in	  the	  ventral	  striatum	  and	  ventral	  midbrain	  following	  chronic	  opioid	  administration	  contribute	  to	  the	  development	  and	  maintenance	  of	  opiate	  addiction	  [16].	  Drugs	  have	  effects	  over	  time	  to	  induce	  molecular	  changes	  in	  addiction	  pathways	  through	  modifying	  synaptic	  connections.	  Therefore,	  researchers	  have	  investigated	  the	  upregulation	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and	  downregulation	  of	  genes	  in	  the	  ventral	  striatum	  and	  ventral	  midbrain,	  such	  as	  the	  ventral	  tegmentum	  area	  (VTA)	  and	  SNpc	  that	  are	  associated	  with	  addiction,	  in	  order	  to	  assess	  the	  genotype-­‐dependent	  regional	  effects	  of	  morphine	  [16].	  Gene	  expression	  and	  bioinformatics	  analysis	  of	  the	  affected	  genes	  showed	  that	  these	  genes	  were	  associated	  with	  neuroplasticity,	  axonal	  guidance,	  and	  transcription	  of	  micro-­‐RNAs.	  Of	  interest	  from	  the	  results	  was	  spinophilin,	  which	  is	  a	  dendritic	  spine-­‐enriched	  scaffold	  S	  protein	  that	  mediates	  synaptic	  transmission	  and	  DA	  mediated	  plasticity	  in	  the	  striatum.	  Also,	  miRNA	  genes	  H19	  and	  Mirg	  were	  identified	  as	  potential	  targets	  of	  drug-­‐related	  adaptation	  because	  miRNAs	  influence	  dendritic	  architecture	  in	  response	  to	  activity-­‐dependent	  events	  [16].	  Taken	  together,	  these	  results	  suggest	  that	  plasticity	  processes	  may	  be	  involved	  with	  drug	  self-­‐administration	  behavior.	  Interestingly,	  passive	  administration	  behavior,	  produced	  through	  a	  yoked	  control,	  elicits	  lower	  expression	  of	  these	  genes	  suggesting	  that	  self-­‐administration	  and	  passive	  administration	  are	  distinct	  processes	  [16].	  	  	  
Addiction	  initiation	  and	  maintenance	  Following	  the	  identification	  of	  potential	  neural	  substrates	  for	  addiction,	  it	  is	  necessary	  to	  determine	  the	  process	  through	  which	  addiction	  is	  initiated	  and	  maintained.	  For	  years,	  DA	  has	  been	  targeted	  as	  a	  crucial	  player	  in	  addiction	  because	  of	  its	  well-­‐known	  modulation	  of	  reward	  signaling	  in	  the	  NAcc.	  Acute	  administration	  of	  all	  major	  addictive	  drugs	  causes	  increased	  DA	  transmission	  to	  the	  NAcc	  [17]	  and	  is	  important	  for	  the	  perception	  of	  reward	  and	  initiation	  of	  addiction.	  	  Studies	  using	  NR1-­‐DAT-­‐Cre	  mice	  have	  shown	  that	  NMDARs	  in	  dopaminergic	  cells	  are	  important	  for	  CPP	  reinstatement	  and	  drug	  self-­‐administration	  and	  may	  be	  involved	  in	  recall	  of	  previously	  learned	  behaviors	  in	  response	  to	  salient	  stimuli	  [17].	  These	  dopaminergic	  projections	  trigger	  a	  behavioral	  response	  to	  motivational	  events	  and	  show	  that	  DA	  signaling	  is	  important	  for	  learned	  behavior	  [18].	  	  Once	  the	  association	  is	  learned,	  relapse	  is	  thought	  to	  arise	  from	  plastic	  changes	  that	  alter	  excitatory	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transmission	  at	  the	  dendrites	  of	  DA	  neurons	  in	  the	  VTA	  or	  SNpc,	  which	  cause	  DA	  neurons	  to	  fire	  onto	  the	  NAcc	  [18].	  	  The	  development	  of	  drug	  addiction	  begins	  with	  initial,	  acute	  exposures	  to	  the	  drug	  and	  the	  onset	  of	  acute	  drug	  symptoms.	  DA	  receptors	  in	  the	  NAcc	  are	  triggered	  by	  dopamine	  release	  from	  the	  VTA,	  and	  these	  receptors	  activate	  cAMP-­‐dependent	  protein	  kinase	  A	  (PKA).	  This	  leads	  to	  PKA-­‐induced	  phosphorylation	  of	  CREB,	  which	  induces	  immediate	  early	  gene	  (IEG)	  products	  such	  as	  c-­‐
Fos.	  IEGs	  promote	  plastic	  changes	  at	  the	  synapse	  that	  increase	  the	  perceived	  reward	  and,	  perhaps,	  contribute	  to	  the	  transition	  from	  recreational	  to	  addictive	  drug	  use	  [18].	  Research	  using	  drd2-­‐eGFP	  or	  drd1a-­‐eGFP	  bacterial	  artificial	  chromosome	  (BAC)	  transgenic	  mice	  has	  revealed	  that	  there	  are	  two	  distinct	  neuronal	  populations	  in	  the	  NAcc.	  The	  NAcc	  is	  predominantly	  composed	  of	  medium-­‐sized	  spiny	  neurons	  (MSNs)	  and	  these	  MSNs	  can	  be	  divided	  into	  two	  subsets;	  one	  subset	  expresses	  dopaminergic	  D1-­‐type	  receptors	  (D1Rs)	  and	  the	  other	  subset	  expresses	  dopaminergic	  D2-­‐type	  receptors	  (D2Rs).	  Chronic	  injection	  of	  morphine	  causes	  c-­‐Fos	  protein	  expression	  predominantly	  in	  D2Rs	  [19,	  20],	  while	  a	  single	  morphine	  injection	  causes	  c-­‐Fos	  protein	  expression	  predominantly	  in	  D1Rs.	  Separation	  of	  these	  NAcc	  specific	  neuronal	  populations	  contributes	  to	  our	  understanding	  of	  the	  neuronal	  basis	  of	  addiction	  and	  other	  associated	  disorders.	  	   Despite	  the	  strong	  focus	  on	  DA	  in	  modulating	  addiction,	  DA	  is	  only	  responsible	  for	  the	  initiation	  of	  addiction,	  and	  studies	  have	  shown	  that	  glutamatergic	  projections	  from	  the	  PFC	  to	  the	  NAcc	  are	  equally,	  if	  not	  more,	  important	  for	  maintenance	  [18].	  These	  glutamatergic	  projections	  to	  the	  NAcc	  core	  are	  responsible	  for	  driving	  the	  drug-­‐seeking,	  compulsive	  behavior	  that	  characterizes	  addiction	  [18].	  	  This	  behavior	  is	  thought	  to	  stem	  from	  three	  simultaneous	  synaptic	  changes.	  First,	  alterations	  in	  G-­‐protein	  signaling	  increase	  the	  excitability	  of	  glutamatergic	  neurons	  projecting	  to	  the	  NAcc.	  Second,	  the	  dysregulation	  of	  metabotropic	  glutamate	  inhibitory	  autoreceptors	  increases	  presynaptic	  glutamate	  release.	  Lastly,	  the	  dysregulation	  of	  postsynaptic	  density	  proteins	  alters	  the	  postsynaptic	  responsiveness	  to	  this	  increased	  glutamate	  release	  from	  the	  presynaptic	  terminal	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[18].	  	  While	  blocking	  the	  dopaminergic	  or	  glutamatergic	  projections	  to	  the	  NAcc	  prevents	  the	  initiation	  and	  reinstatement	  of	  addictive	  behavior,	  respectively,	  these	  results	  show	  that	  pharmacologically	  targeting	  the	  PFC	  glutamatergic	  projections	  to	  the	  NAcc	  may	  ameliorate	  the	  compulsive	  drug-­‐seeking	  behavior	  that	  contributes	  to	  the	  pathology	  of	  addiction.	  Continual	  administration	  of	  drugs	  of	  abuse	  leads	  to	  tolerance,	  which	  is	  characterized	  by	  the	  need	  for	  increased	  drug	  administration	  in	  order	  to	  achieve	  the	  same	  amount	  of	  analgesia	  attained	  at	  the	  beginning	  of	  drug	  use.	  Tolerance	  is	  a	  distinctive	  trait	  of	  opioid	  drug	  addiction,	  and	  morphine	  tolerance	  and	  addiction	  are	  believed	  to	  be	  mediated	  by	  complex	  changes	  in	  neural	  plasticity	  [7].	  Elucidating	  the	  neural	  substrates	  of	  addiction	  is	  important	  for	  understanding	  the	  cellular	  mechanisms	  of	  tolerance	  and	  addiction,	  and	  though	  NMDA	  receptors	  have	  been	  a	  primary	  focus	  of	  this	  research,	  recent	  literature	  has	  shown	  increasing	  evidence	  that	  glial	  cells	  may	  play	  an	  important	  role	  in	  mediating	  addiction.	  	  
Glial	  pathways	  Though	  several	  lines	  of	  evidence	  suggest	  that	  glial	  activation	  may	  play	  a	  role	  in	  addiction,	  the	  specific	  mechanism	  through	  which	  this	  process	  takes	  place	  is	  still	  under	  investigation.	  It	  is	  proposed	  that	  opioids	  do	  not	  cause	  glial	  activation	  through	  classical	  opioid	  receptors,	  but	  instead	  induce	  glial	  activation	  through	  a	  class	  of	  pattern	  recognition	  receptors	  called	  toll-­‐like	  receptors	  (TLRs),	  specifically	  TLR4	  [4].	  However,	  opposing	  evidence	  suggests	  that	  microglial	  activation	  is	  caused	  by	  a	  mechanism	  independent	  of	  the	  TLR4	  pathway	  in	  the	  development	  of	  morphine	  tolerance	  [21].	  The	  reason	  that	  the	  TLR4	  pathway	  has	  been	  identified	  as	  a	  possible	  mechanism	  for	  opioid	  action	  is	  due	  to	  the	  accumulating	  evidence	  that	  selective,	  acute	  antagonism	  of	  TLR4	  results	  in	  reversal	  of	  neuropathic	  pain	  and	  potentiation	  of	  opioid	  analgesia	  [4].	  One	  novel	  drug,	  plus-­‐(+)	  naloxone,	  has	  been	  widely	  used	  to	  block	  TLR4	  activation-­‐induced	  gene	  expression	  of	  both	  proinflammatory	  cytokines	  and	  a	  microglia	  marker	  CD11b	  [4,	  22,	  23].	  Assuming	  that	  opioids	  work	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through	  the	  TLR4	  pathway,	  extensive	  studies	  have	  been	  done	  investigating	  the	  effects	  of	  acute	  TLR4	  antagonism,	  TLR4	  genetic	  knockout,	  and	  blockade	  of	  TLR4	  downstream	  signaling	  (e.g.,	  MyD88)	  on	  morphine	  withdrawal	  and	  analgesia	  [22].	  It	  has	  been	  shown	  that	  disrupting	  the	  TLR4	  pathway	  leads	  to	  reduction	  of	  withdrawal	  symptoms	  [24]	  and	  increased	  analgesia	  [22,	  24].	  Other	  opioid	  manipulations	  have	  included	  studies	  using	  several	  non-­‐specific	  glial	  activation	  inhibitors	  such	  as	  ibudilast,	  minocycline,	  and	  propentofylline	  [4,	  21,	  22,	  24].	  These	  drugs	  were	  used	  as	  pharmacological	  interventions	  and	  studied	  for	  their	  ability	  to	  inhibit	  glial	  activation	  or	  proinflammatory	  cytokine	  actions,	  which	  ultimately	  improved	  the	  clinical	  efficacy	  of	  the	  tested	  opioids	  [22].	  One	  suggested	  hypothesis	  for	  the	  molecular	  mechanism	  of	  microglial	  activation	  by	  morphine	  is	  the	  binding	  of	  myeloid	  differentiation	  protein	  2	  (MD-­‐2),	  an	  accessory	  protein	  of	  TLR4,	  to	  morphine.	  Morphine	  binding	  to	  MD-­‐2	  causes	  TLR4/MD-­‐2	  oligomerization	  and	  subsequent	  TLR4	  cascade	  signaling	  [5].	  	  In	  light	  of	  this	  hypothesis,	  there	  are	  opposing	  studies	  that	  reject	  the	  concept	  of	  TLR4	  involvement	  in	  glial	  activation.	  	  In	  these	  studies,	  it	  is	  shown	  that	  glial	  activation	  mediates	  opioid	  tolerance	  because	  minocycline,	  a	  selective	  glial	  inhibitor,	  attenuates	  the	  development	  of	  tolerance	  in	  mice.	  Mutation	  or	  deletion	  of	  the	  TLR4	  gene,	  however,	  does	  not	  affect	  the	  development	  of	  tolerance,	  which	  suggests	  that	  tolerance	  is	  mediated	  by	  microglial	  activation	  independent	  of	  TLR4	  [21].	  In	  addition,	  CD11b	  mRNA	  is	  elevated	  in	  both	  TLR4	  knockouts	  and	  WTs	  in	  response	  to	  morphine	  [21].	  Previous	  studies	  supporting	  TLR4	  activation	  of	  glia	  have	  not	  focused	  specifically	  on	  tolerance	  [4,	  22,	  23],	  but	  tolerance	  is	  directly	  related	  to	  analgesia	  potential,	  which	  is	  enhanced	  through	  TLR4	  antagonism.	  The	  analgesic	  potency	  of	  morphine	  is	  also	  threefold	  higher	  in	  TLR4-­‐knockout	  mice	  compared	  to	  WTs.	  Therefore,	  tolerance	  may	  be	  discernible	  if	  mice	  are	  given	  lower	  doses	  of	  opioids.	  	  Current	  studies	  opposing	  TLR4-­‐mediated	  glial	  activation	  have	  only	  investigated	  results	  based	  on	  WT	  and	  TLR4-­‐knockout	  mice	  given	  equivalent	  doses,	  but	  it	  is	  speculated	  that	  similar	  tolerance	  is	  induced	  [21].	  Given	  these	  data,	  it	  is	  still	  controversial	  whether	  opioids	  cause	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glial	  activation	  through	  the	  TLR4	  cascade	  or	  another	  closely	  related	  nonclassical	  opioid	  receptor	  pathway.	  Other	  targets	  of	  interest	  include	  TLR2	  and	  P2X4	  and	  P2X7	  receptors	  [21].	  	  The	  basic	  hypothesis	  for	  the	  mechanism	  through	  which	  glial	  activation	  affects	  morphine	  tolerance	  is	  separated	  into	  two	  steps.	  First,	  it	  is	  proposed	  that	  morphine	  acts	  directly	  on	  glial	  cells	  and	  alters	  their	  metabolism,	  morphology,	  and	  function	  [7,	  25].	  This	  activation	  induces	  increased	  activity	  of	  glial	  cells,	  which	  release	  a	  variety	  of	  substances	  that	  have	  been	  associated	  with	  morphine	  tolerance,	  such	  as	  nitric	  oxide,	  an	  important	  cellular	  signaling	  molecule,	  and	  cyclooxygenase	  products,	  along	  with	  multiple	  neurotransmitters	  that	  contribute	  to	  neuronal	  plasticity	  [7,	  25].	  Glial	  cells	  are	  also	  responsible	  for	  the	  uptake	  of	  amino	  acid	  neurotransmitters,	  such	  as	  GABA	  and	  glutamate,	  and	  are	  therefore	  intimately	  associated	  with	  synaptic	  transmission	  regulation	  [7].	  Activated	  glia	  that	  contribute	  to	  morphine-­‐induced	  reward	  are	  generally	  found	  in	  the	  NAcc,	  but	  the	  role	  of	  microglia	  in	  this	  region	  remains	  unclear	  [26].	  One	  recent	  study	  shows	  that	  chronic	  morphine	  treatment	  induces	  activation	  of	  p38	  in	  NAcc	  microglia	  [26].	  p38	  is	  a	  mitogen-­‐activated	  protein	  kinase	  (MAPK)	  that	  may	  be	  associated	  with	  degenerative	  disease	  of	  the	  CNS	  and	  may	  mediate	  morphine-­‐induced	  responses	  like	  tolerance	  and	  analgesia	  [26].	  Conditioned	  place	  preference	  (CPP)	  is	  a	  paradigm	  used	  to	  demonstrate	  the	  acquisition	  of	  addiction.	  Mice	  are	  conditioned	  to	  associate	  a	  certain	  context	  with	  a	  drug	  and	  another	  context	  with	  the	  vehicle	  in	  which	  the	  drug	  was	  administered.	  After	  the	  association	  has	  been	  acquired,	  the	  strength	  of	  the	  association	  between	  context	  and	  drug	  is	  assessed	  through	  measuring	  the	  time	  spent	  in	  both	  the	  drug	  and	  vehicle	  associated	  contexts.	  This	  paradigm	  can	  also	  be	  used	  to	  study	  the	  tendency	  for	  relapse	  if	  mice	  are	  exposed	  to	  the	  drug	  context	  without	  administration	  of	  drug	  (extinction	  phase)	  and	  then	  later	  reintroduced	  to	  a	  priming	  (low	  or	  threshold)	  dose	  of	  the	  drug.	  Studies	  show	  that	  p38	  inhibitor	  (administered	  before	  morphine	  treatment)	  prevents	  acquisition	  of	  CPP.	  In	  addition,	  minocycline,	  a	  microglia	  inhibitor,	  was	  also	  able	  to	  prevent	  CPP	  acquisition.	  	  Interestingly,	  p38	  inhibitor	  and	  minocycline	  were	  not	  able	  to	  prevent	  expression	  of	  CPP	  after	  it	  was	  established;	  however,	  chronic	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injection	  of	  the	  p38	  inhibitor	  was	  able	  to	  interrupt	  CPP	  maintenance.	  The	  need	  for	  chronic	  injection	  of	  an	  inhibitor	  in	  order	  to	  attenuate	  CPP	  maintenance	  suggests	  that	  these	  effects	  may	  take	  place	  through	  the	  long-­‐term	  release	  of	  cytokines	  and	  neurotrophic	  factors	  from	  activated	  microglia.	  Cytokines	  and	  neurotrophic	  factors	  contribute	  to	  long-­‐term	  adaptations	  in	  the	  neural	  circuit	  [27];	  therefore,	  it	  is	  plausible	  that	  these	  molecules	  may	  have	  an	  effect	  on	  drug	  addiction	  substrates.	  These	  results	  suggest	  that	  p38	  signaling	  in	  NAcc	  microglia	  may	  be	  critical	  for	  acquisition	  and	  maintenance,	  but	  not	  expression	  of	  morphine	  CPP	  [26].	  However,	  p38	  is	  not	  exclusive	  to	  microglia,	  so	  these	  data	  must	  be	  interpreted	  with	  caution.	  	  
Early-­‐life	  experiences	  In	  addition	  to	  elucidating	  the	  neural	  and	  cellular	  mechanisms	  of	  addiction,	  it	  is	  important	  to	  identify	  the	  environmental	  factors	  that	  play	  a	  role	  in	  initiating	  and	  mediating	  addiction.	  Several	  factors	  such	  as	  genetics,	  physiology,	  and	  environment,	  specifically	  early-­‐life	  environment,	  have	  been	  shown	  to	  significantly	  affect	  an	  individual’s	  risk	  of	  addiction.	  Early	  life	  stressors	  in	  rodents	  increase	  drug	  self-­‐administration	  [28],	  alcohol	  intake	  [29],	  and	  alter	  CPP	  [30],	  suggesting	  that	  early-­‐life	  experiences	  may	  program	  the	  brain	  and	  prompt	  behaviors	  that	  ultimately	  impact	  neural	  function	  in	  adulthood	  and	  contribute	  to	  addiction	  liability.	  Recent	  literature	  has	  shown	  that	  naturally	  occurring	  variations	  in	  maternal	  care	  mediate	  significant	  variations	  in	  offspring	  cognitive	  development	  [31].	  Handling	  paradigms	  are	  used	  to	  manipulate	  the	  quality	  and	  quantity	  of	  maternal	  care,	  which	  includes	  behaviors	  such	  as	  licking,	  grooming,	  and	  arched	  back	  nursing.	  Handling	  paradigms	  intended	  to	  increase	  maternal	  care	  behaviors	  separate	  mothers	  from	  their	  pups	  for	  a	  period	  of	  at	  least	  15	  minutes	  before	  returning	  them	  to	  the	  same	  cage.	  This	  brief	  separation	  induces	  an	  innate	  increase	  in	  maternal	  behaviors	  as	  compared	  to	  that	  of	  mothers	  who	  remained	  undisturbed	  [31].	  Neonatal	  handling	  paradigms	  have	  shown	  that	  early	  life	  experiences	  change	  the	  responsiveness	  of	  a)	  mesocorticolimbic	  DA	  neurons	  to	  stress	  and	  psychostimulants	  [32],	  b)	  the	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microglial	  activation	  in	  response	  to	  an	  immune	  challenge	  [31],	  and	  c)	  the	  rewarding	  effect	  of	  morphine	  and	  tendency	  for	  morphine	  relapse	  [2].	  Recently	  in	  our	  laboratory,	  handling	  experiments	  in	  rats	  have	  shown	  that	  maternal	  care	  attenuates	  morphine-­‐induced	  glial	  activation,	  increases	  basal	  levels	  of	  anti-­‐inflammatory	  cytokine	  interleukin	  (IL)-­‐10	  within	  microglia	  in	  the	  NAcc,	  and	  prevents	  morphine	  relapse	  in	  adulthood	  [2].	  The	  increase	  in	  basal	  IL-­‐10	  occurs	  because	  of	  decreased	  methylation	  of	  the	  IL-­‐10	  gene	  specifically	  within	  microglia.	  These	  neonatal	  handling	  effects	  can	  be	  replicated	  pharmacologically	  in	  adults	  with	  administration	  of	  ibudliast,	  a	  glial	  modulator.	  Ibudilast	  increases	  IL-­‐10	  expression,	  inhibits	  morphine-­‐induced	  glial	  activation	  within	  the	  NAcc,	  and	  prevents	  morphine	  relapse.	  These	  novel	  findings	  suggest	  that	  IL-­‐10	  may	  modulate	  the	  negative	  effects	  of	  microglial	  activation	  in	  response	  to	  morphine	  and	  that	  increases	  of	  IL-­‐10	  in	  the	  NAcc	  may	  decrease	  the	  tendency	  for	  relapse,	  especially	  in	  vulnerable	  individuals	  [2].	  Based	  on	  this	  previous	  work,	  we	  hope	  to	  establish	  a	  causal	  relationship	  for	  microglial	  IL-­‐10	  in	  drug	  resilience.	  	  	  
General	  Aims	  In	  order	  to	  translate	  our	  previous	  research	  to	  a	  mouse	  model,	  it	  is	  necessary	  to	  investigate	  the	  molecular	  expression	  profile	  of	  mice	  in	  response	  to	  morphine	  administration.	  With	  these	  exploratory	  experiments,	  I	  seek	  to	  examine	  the	  following	  questions:	  1)	  in	  mice,	  is	  there	  an	  effect	  of	  time,	  dose,	  or	  brain	  region	  on	  glial	  activation	  in	  response	  to	  morphine	  administration?	  and,	  2)	  Given	  the	  evidence	  suggesting	  a	  possible	  TLR4	  mechanism	  of	  glial	  activation,	  is	  there	  a	  TLR4	  gene	  dose	  response	  in	  mice	  with	  respect	  to	  learning?	  The	  latter	  question	  stems	  from	  the	  fact	  that	  learning	  is	  an	  important	  measure	  of	  cognition,	  and	  cognition	  is	  closely	  related	  to	  all	  addiction	  processes.	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Materials	  and	  Methods	  
Experiment	  1:	  Morphine	  Exposure	  in	  Mice	  Forty-­‐eight	  adult	  male	  C57	  BL/6	  mice	  were	  obtained	  from	  Charles	  River	  Laboratories	  (Raleigh,	  NC)	  and	  housed	  in	  ventilated	  polypropylene	  cages	  with	  ad	  libitum	  access	  to	  food	  and	  water.	  The	  colony	  was	  maintained	  at	  22°C	  on	  a	  12:12	  h	  light-­‐	  dark	  cycle	  (lights	  on	  at	  7:00	  A.M.	  Eastern	  Standard	  Time).	  	  
	  	  	  	  	  Injections	  and	  Perfusions	  The	  48	  mice	  were	  divided	  into	  6	  groups	  based	  on	  2	  different	  morphine	  doses	  and	  3	  sacrifice	  time	  points.	  This	  resulted	  in	  7	  animals	  per	  dose/time	  point	  combination	  group	  plus	  one	  mouse	  per	  time	  point	  group	  designated	  as	  a	  saline	  control.	  Animals	  were	  sacrificed	  at	  either	  5,	  40,	  or	  60	  minutes	  following	  morphine	  or	  saline	  administration.	  Morphine-­‐treated	  animals	  were	  given	  3	  mg/kg	  or	  10	  mg/kg	  subcutaneous	  (s.c.)	  morphine	  injections.	  Controls	  were	  given	  s.c.	  saline	  injections.	  At	  the	  designated	  time	  point,	  mice	  were	  anesthetized	  with	  0.2	  mL	  of	  a	  ketamine-­‐xylazine	  cocktail	  and	  sacrificed	  by	  transcardial	  perfusion	  with	  0.9%	  saline.	  Brains	  were	  then	  extracted	  and	  cut	  in	  half.	  One	  hemisphere	  was	  placed	  in	  a	  4%	  paraformaldehyde	  solution	  for	  histology.	  Prefrontal	  cortex,	  nucleus	  accumbens	  (NAcc),	  and	  hippocampus	  (HP)	  samples	  were	  extracted	  from	  the	  remaining	  hemisphere	  and	  immediately	  flash	  frozen	  in	  isopentane	  for	  later	  RNA	  extraction	  and	  PCR	  analysis.	  
	  	  	  	  	  Tissue	  RNA	  extraction	  	  The	  frozen	  samples	  from	  the	  nucleus	  accumbens	  and	  the	  hippocampus	  were	  homogenized	  in	  TRIzol	  (Life	  Technologies,	  Grand	  Island,	  NY)	  and	  RNA	  was	  precipitated	  using	  chloroform:glucagon:isopropyl	  alcohol	  extraction.	  Following	  RNA	  isolation,	  the	  samples	  were	  treated	  with	  DNase,	  and	  complementary	  DNA	  (cDNA)	  was	  synthesized	  from	  100	  ng	  of	  isolated	  RNA	  using	  the	  Qiagen	  QuantiTect	  Reverse	  Transcription	  Kit	  (Valencia,	  CA,	  USA)	  or	  from	  500	  ng	  of	  isolated	  RNA	  using	  the	  RT2	  First	  Strand	  Kit	  (SABiosciences/Qiagen,	  Frederick,	  MD,	  USA).	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  Quantitative	  Real-­‐time	  PCR	  and	  Analysis	  Gene	  expression	  was	  measured	  using	  quantitative	  real-­‐time	  PCR	  with	  primers	  designed	  to	  measure	  mouse	  cytokines,	  chemokines	  and	  receptors	  using	  the	  RT2	  SYBRÒ	  Green	  qPCR	  Master	  Mix	  (Cat.	  No.	  330500,	  Qiagen,	  Valencia,	  CA,	  USA)	  following	  the	  manufacturer’s	  protocol.	  Seven	  mice	  per	  treatment	  group	  plus	  saline	  controls	  were	  analyzed	  according	  to	  this	  method.	  
qRT-­‐PCR	  analysis.	  Threshold	  amplification	  cycle	  number	  (Ct)	  was	  determined	  for	  each	  reaction	  within	  the	  linear	  phase	  of	  the	  amplification	  plot	  and	  relative	  gene	  expression	  was	  determined	  using	  the	  2-­‐ΔΔCT	  method	  [33,	  34].	  Relative	  gene	  expression	  across	  groups	  was	  compared	  using	  either	  a)	  a	  three-­‐way	  ANOVA	  with	  brain	  region	  (HP	  or	  NAcc),	  dose	  (saline,	  3	  mg/kg,	  or	  10	  mg/kg),	  and	  time	  (5	  min.,	  40	  min.,	  60	  min.)	  as	  factors	  or	  b)	  a	  one-­‐way	  ANOVA	  with	  time	  point	  as	  a	  factor,	  comparing	  only	  NAcc	  tissue	  from	  mice	  that	  received	  either	  saline	  or	  3	  mg/kg	  of	  morphine.	  	  	  
	  	  	  	  	  Primer	  specifications.	  	  Real-­‐time	  quantitative	  PCR	  primers	  were	  obtained	  from	  SABiosciences/Qiagen	  from	  Cat	  No.	  PAMM-­‐022ZA	  or	  designed	  by	  our	  laboratory	  and	  purchased	  from	  Sigma–Aldrich	  (St.	  Louis,	  MO,	  USA).	  Sequences:	  GAPDH:	  Fwd	  –	  GGTCACCAGGGCTGCCATTT,	  Rev	  –	  TGGGCTTCCCGTTGATGACA;	  IL-­‐10	  (IL-­‐10):	  Fwd	  –	  GGACAACATACTGCTAACCGAC,	  Rev	  –	  TGCTCCTTGATTTCTGGGC;	  Cd11b:	  Fwd	  –	  CTATTTGTTCGGCTCCAAC,	  Rev	  –	  GCATCAAAGAGAACAAGG;	  CCL4:	  Fwd	  –	  GATTACTATGAGACCAGCAG,	  Rev	  –	  CTCCAGCGGCAGGGCAGG;	  CCL17	  Fwd	  –	  TGAGGCATTTGGAGACGCCA,	  Rev	  –	  GCACTACAGGCGAACACA;	  CCL25	  Fwd	  –	  ATAATCCCCCAACCTGTGCTC,	  Rev–	  TGAGTGTGTGAGAGTGCCTA.	  
	  
Experiment	  2:	  Learning	  and	  Memory	  in	  TLR4	  HET	  and	  KO	  Mice	  Knockout	  (KO)	  mice	  are	  genetically	  engineered	  to	  have	  a	  missing	  or	  disrupted	  copy	  of	  a	  specific	  gene.	  Heterozygous	  (HET)	  mice	  have	  one	  copy	  of	  the	  gene	  that	  is	  missing	  or	  disrupted,	  while	  the	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other	  copy	  of	  the	  gene	  is	  intact.	  These	  mice	  were	  bred	  from	  a	  TLR4+/-­‐	  HET	  female	  and	  TLR4	  -­‐/-­‐	  KO	  male;	  therefore,	  we	  could	  compare	  TLR4	  HET	  and	  KO	  littermates	  to	  see	  if	  there	  was	  a	  gene	  dose	  effect	  on	  learning	  or	  memory.	  Ten	  adult	  male	  and	  10	  adult	  female	  TLR4	  HET	  and	  TLR4	  KO	  mice	  bred	  on	  a	  C57	  BL/6	  background	  were	  obtained	  from	  the	  laboratory	  of	  Dr.	  Richard	  Auten	  at	  Duke	  University	  and	  housed	  in	  ventilated	  polypropylene	  cages	  with	  ad	  libitum	  access	  to	  food	  and	  water.	  The	  colony	  was	  maintained	  at	  22°C	  on	  a	  12:12	  h	  light-­‐	  dark	  cycle	  (lights	  on	  at	  7:00	  A.M.	  Eastern	  Standard	  Time).	  	  	  	  
	  	  	  	  	  Fear	  conditioning	  Addiction	  relies	  heavily	  on	  cognitive	  associations	  made	  between	  drugs	  and	  physiological	  or	  environmental	  cues.	  This	  close	  relationship	  is	  a	  result	  of	  the	  strong	  role	  that	  cognitive	  association	  plays	  in	  forming	  patterns,	  habits,	  and	  general	  addictive	  behaviors.	  Therefore,	  intact	  learning	  is	  a	  necessary	  measure	  used	  to	  verify	  transgenic	  animal	  model	  viability.	  Fear	  conditioning	  paradigms	  are	  routinely	  used	  to	  measure	  the	  cognitive	  ability	  of	  mice	  to	  form	  associations	  between	  conditioned	  and	  unconditioned	  stimuli.	  Therefore,	  we	  compared	  TLR4	  knockout	  mice’s	  performance	  in	  a	  fear-­‐conditioning	  paradigm	  with	  that	  of	  wild	  type	  mice	  in	  order	  to	  determine	  if	  cognition	  has	  been	  compromised	  as	  a	  result	  of	  transgenic	  breeding.	  All	  subjects	  received	  three	  pairings	  of	  an	  auditory	  cue	  (tone;	  conditioned	  stimulus	  (CS))	  and	  2-­‐s	  0.8mA	  shock	  (unconditioned	  stimulus	  (US)),	  with	  2	  minutes	  of	  exploration	  before	  the	  first	  tone-­‐shock	  pairing	  and	  90	  s	  of	  exploration	  between	  each	  of	  the	  subsequent	  pairings.	  Mice	  were	  carried	  from	  their	  cages	  to	  and	  from	  the	  testing	  chamber	  in	  identical	  black	  (males)	  or	  red	  (females)	  buckets	  to	  establish	  a	  specific	  routine	  and	  environment	  for	  contextual	  fear	  testing.	  	  	  	  
	  	  	  	  	  Memory	  testing	  and	  fear	  conditioning	  scoring	  Forty-­‐eight	  hours	  following	  conditioning,	  mice	  were	  given	  a	  contextual	  fear	  conditioning	  memory	  test,	  which	  consisted	  of	  6	  minutes	  in	  the	  original	  testing	  chamber.	  Contextual	  fear	  conditioning	  relies	  on	  the	  hippocampus	  and	  involves	  forming	  an	  association	  between	  the	  testing	  chamber	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environment	  and	  the	  aversive	  footshock.	  The	  same	  containers	  used	  to	  carry	  the	  mice	  during	  conditioning	  were	  used	  during	  memory	  testing.	  Three	  hours	  following	  the	  contextual	  test,	  mice	  were	  given	  an	  auditory	  test,	  which	  consisted	  of	  a	  3-­‐minute	  pre-­‐CS	  period	  and	  a	  3-­‐minute	  CS	  period	  in	  a	  novel	  testing	  chamber.	  Auditory-­‐cued	  fear	  conditioning	  relies	  on	  the	  amygdala	  and	  involves	  forming	  an	  association	  between	  the	  tone	  cue	  (CS)	  and	  the	  aversive	  footshock	  (US).	  During	  both	  the	  contextual	  and	  auditory	  tests,	  mice	  were	  scored	  for	  freezing	  behavior	  by	  two	  independent	  raters.	  Every	  10	  s,	  each	  mouse	  was	  judged	  as	  either	  freezing	  or	  active.	  Freezing	  is	  defined	  as	  the	  absence	  of	  visible	  movement,	  excluding	  respiration.	  Mice	  were	  scored	  for	  freezing	  behavior	  during	  the	  entirety	  of	  the	  testing	  period,	  which	  began	  immediately	  after	  the	  mouse	  was	  placed	  in	  the	  testing	  chamber.	  
	  	  	  	  	  Sacrifice	  and	  Immunohistochemistry	  for	  Iba1	  Forty-­‐eight	  hours	  following	  memory	  testing,	  animals	  were	  deeply	  anaesthetized	  with	  0.2	  mL	  of	  a	  ketamine-­‐xylazine	  cocktail	  and	  sacrificed	  by	  transcardial	  perfusion	  of	  0.9%	  saline	  followed	  by	  4%	  paraformaldehyde	  in	  0.1M	  phosphate	  buffer	  (PB).	  Brains	  were	  extracted	  and	  stored	  in	  a	  4%	  paraformaldehyde	  solution	  for	  2	  days.	  Then	  brains	  were	  then	  transferred	  to	  a	  30%	  sucrose	  and	  0.1%	  sodium	  azide	  solution	  to	  cryoprotect	  them	  before	  slicing.	  Brains	  were	  exhaustively	  sliced	  at	  40	  μm	  on	  a	  cryostat	  and	  stored	  as	  free-­‐floating	  sections	  in	  0.1%	  sodium	  azide.	  Free-­‐floating	  sections	  were	  initially	  rinsed	  for	  3	  ×	  5	  min	  in	  0.01	  M	  phosphate-­‐buffered	  saline	  (PBS)	  and	  also	  rinsed	  before	  each	  subsequent	  step,	  excluding	  the	  step	  between	  the	  blocking	  and	  primary	  antibody	  steps.	  Next,	  sections	  were	  washed	  in	  50%	  methanol	  for	  30	  min.	  Sections	  were	  then	  quenched	  in	  0.6%	  hydrogen	  peroxide	  for	  30	  min	  and	  then	  blocked	  for	  another	  30	  min	  in	  5%	  normal	  goat	  serum	  and	  0.3%	  Triton-­‐X	  to	  block	  and	  permeabilize,	  respectively,	  in	  PBS	  (blocking	  buffer).	  Following	  this	  blocking	  step,	  sections	  were	  incubated	  overnight	  at	  room	  temperature	  in	  Iba1	  antibody	  (1:10,000,	  rabbit	  polyclonal,	  Wako	  Pure	  Chemical	  Industries,	  Ltd.)	  in	  blocking	  buffer.	  The	  following	  day,	  sections	  were	  incubated	  for	  2	  h	  at	  room	  temperature	  in	  a	  solution	  of	  biotinylated	  anti-­‐rabbit	  antibody	  (1:200,	  Vector	  Laboratories,	  Burlingame,	  CA,	  USA)	  in	  blocking	  buffer.	  The	  Avidin–Biotin	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Complex	  (ABC)	  method	  was	  used	  to	  bind	  a	  complex	  of	  streptavidin–biotin	  peroxidase	  to	  the	  secondary	  antibody	  (1	  h	  incubation),	  which	  was	  then	  developed	  with	  diaminobenzidine	  (DAB,	  Vector	  Laboratories,	  Burlingame,	  CA,	  USA)	  for	  20-­‐45	  min	  to	  produce	  a	  colorimetric	  stain.	  Sections	  were	  mounted	  on	  gel-­‐coated	  slides,	  dehydrated	  and	  coverslipped	  with	  Permount.	  
	  	  	  	  	  Densitometry	  for	  TLR4	  HET	  and	  KO	  brains	  Quantification	  of	  Iba1-­‐positive	  cells	  was	  performed	  using	  ScionImage	  densitometry.	  Five	  sections	  per	  mouse	  were	  analyzed	  for	  the	  dentate	  gyrus,	  CA1,	  and	  CA3	  sub-­‐regions	  of	  the	  hippocampus.	  Digitized	  images	  of	  each	  region	  of	  interest	  (ROI)	  were	  taken	  at	  10X	  using	  a	  Nikon	  Eclipse	  80i	  microscope	  and	  digital	  camera	  on	  a	  Dell	  PC	  running	  PictureFrame	  software.	  Each	  region	  was	  traced	  using	  ScionImage	  after	  converting	  the	  image	  to	  grey	  scale.	  Signal	  pixels	  of	  an	  ROI	  were	  defined	  as	  having	  a	  grey	  value	  of	  3	  SDs	  above	  the	  mean	  grey	  value	  of	  a	  cell-­‐poor	  area	  close	  to	  or	  within	  the	  ROI.	  The	  number	  of	  pixels	  and	  the	  average	  grey	  values	  above	  the	  set	  background	  were	  then	  computed	  for	  each	  ROI	  and	  multiplied	  by	  the	  area	  of	  the	  traced	  ROI,	  resulting	  in	  an	  integrated	  area	  density	  measurement.	  All	  values	  for	  each	  of	  the	  5	  sections	  per	  rat	  were	  averaged	  to	  obtain	  a	  single	  integrated	  density	  value	  per	  sub-­‐region	  of	  interest	  for	  each	  rat.	  A	  two-­‐way	  ANOVA	  was	  used	  to	  analyze	  the	  effects	  of	  genotype	  and	  sex	  on	  the	  individual	  values	  obtained	  for	  each	  rat.	  	  
	  	  	  	  	  Statistics	  Data	  for	  morphine	  exposure	  in	  mice	  was	  analyzed	  using	  a	  3-­‐way	  ANOVA	  comparing	  time	  point,	  dose,	  and	  region.	  Based	  on	  the	  present	  data,	  we	  performed	  several	  exploratory	  t-­‐tests	  to	  investigate	  differences	  between	  time	  point	  values.	  IL-­‐10	  values	  are	  typically	  hard	  to	  obtain	  because	  of	  the	  nature	  of	  expression;	  therefore,	  the	  limited	  data	  available	  was	  used	  to	  drive	  the	  statistics	  for	  IL-­‐10.	  Ongoing	  analyses	  for	  the	  Iba-­‐1/IL-­‐10	  double	  label	  tissue	  is	  ongoing	  and	  should	  show	  us	  if	  IL-­‐10	  protein	  is	  upregulated	  or	  specifically	  distributed	  in	  either	  the	  HP	  or	  NAcc.	  Data	  for	  TLR4	  HET	  and	  KO	  mice	  was	  analyzed	  using	  a	  2-­‐way	  ANOVA	  comparing	  sex	  and	  genotype.	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Results	  
Experiment	  1:	  Morphine	  Exposure	  in	  Mice	  To	  assess	  the	  response	  to	  morphine	  with	  respect	  to	  time	  and	  dose,	  we	  measured	  the	  gene	  expression	  of	  several	  important	  inflammatory	  markers	  and	  microglial	  cytokines	  and	  chemokines	  using	  real-­‐time	  PCR.	  We	  find	  that	  longer	  time	  points	  may	  be	  important	  for	  morphine	  administration	  and	  result	  in	  an	  increase	  in	  specific	  cytokine	  production.	  Our	  results	  show	  a	  trending	  difference	  in	  CCL4	  with	  respect	  to	  dose	  by	  region	  (F(2,	  93)=	  2.64,	  p=0.078),	  with	  a	  greater	  response	  in	  the	  NAcc	  compared	  to	  HP	  at	  lower	  doses	  and	  a	  greater	  response	  in	  the	  HP	  compared	  to	  NAcc	  at	  higher	  doses	  (Fig.	  1).	  Also,	  for	  CCL4,	  there	  was	  a	  trending	  difference	  between	  the	  5	  and	  60	  minute	  time	  points	  in	  the	  NAcc	  (t(25)=	  -­‐1.83;	  p=0.0792,	  two-­‐tailed),	  but	  not	  in	  the	  HP	  (t(25)=	  -­‐1.06;	  p=	  0.299,	  two-­‐tailed).	  CCL17	  (Fig.	  2)	  gene	  expression	  was	  significantly	  increased	  in	  the	  HP	  compared	  to	  the	  NAcc	  (F(1,93)=	  38.65;	  p<0.001),	  while	  CCL25	  (Fig.	  3)	  expression	  was	  significantly	  increased	  in	  the	  NAcc	  compared	  to	  the	  HP	  (F(1,93)=	  7.20;	  p=	  0.009).	  Additionally,	  IL-­‐10	  differed	  in	  expression	  between	  5	  and	  40	  minutes	  time	  points	  in	  HP	  (Fig.	  4),	  but	  not	  in	  the	  NAcc	  (t(22)=	  -­‐2.47;	  p=	  0.022)	  (Fig.	  5).	  	   We	  also	  utilized	  a	  PCR	  array	  to	  assess	  expression	  of	  85	  immune	  genes	  in	  NAcc	  tissue	  samples.	  Our	  results	  demonstrated	  genes	  that	  are	  possible	  candidates	  for	  further,	  more	  detailed	  analyses.	  The	  following	  genes	  showed	  significant	  changes	  in	  expression	  with	  respect	  to	  experimental	  time	  points	  post	  morphine	  injection	  (Fig.	  6):	  CCL4:	  F(3,8)	  =	  6.122,	  p=0.018;	  CCL8:	  F(3,8)	  =	  4.899,	  p=0.032;	  CCR6:	  F(3,8)	  =	  4.945,	  p=0.031;	  CMKLR1:	  F(3,8)	  =	  9.271,	  p=0.006;	  CXCR7:	  F(3,8)	  =	  5.04,	  p=0.03;	  FPR1:	  F(3.8)	  =	  8.767,	  p=0.007;	  GPR17:	  F(3,8)	  =	  13.681,	  p=0.002;	  Itgb2:	  F(3,8)	  =	  4.745,	  p=0.035;	  MAKP14:	  F(3,8)	  =	  4.233,	  p=0.046;	  CX3CL1:	  F(3.8)	  =	  7.13,	  p=0.012;	  CX3CR1:	  F(3,8)	  =	  6.006,	  p=0.019	  (Fig.	  7).	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Experiment	  2:	  Learning	  in	  TLR4	  HET	  and	  KO	  Mice	  TLR4	  HET	  and	  KO	  mice	  were	  fear	  conditioned	  and	  given	  contextual	  and	  auditory-­‐cued	  memory	  tests	  to	  assess	  learning.	  Our	  results	  show	  that	  contextual	  fear	  conditioning	  differs	  by	  sex,	  with	  females	  freezing	  significantly	  more	  than	  males	  (F(1,19)=	  7.541;	  p=	  0.014)	  (Fig.	  8).	  In	  contrast,	  results	  of	  the	  CS	  conditioning	  (auditory-­‐cued)	  show	  a	  difference	  by	  genotype	  with	  KOs	  freezing	  significantly	  less	  than	  their	  HET	  counterparts	  (F(1,19)=	  6.06;	  p=	  0.026)	  (Fig.	  9).	  This	  difference	  in	  genotype	  is	  primarily	  driven	  by	  female	  HETs	  freezing	  more	  than	  their	  KO	  counterparts,	  while	  male	  HETs	  and	  KOs	  demonstrated	  lower	  freezing	  overall.	  	  
	  
Discussion	  Increasing	  lines	  of	  evidence	  suggest	  that	  microglia	  play	  a	  significant	  role	  in	  pathological	  pain	  and	  addiction.	  Here,	  we	  investigate	  the	  effects	  of	  morphine	  administration	  on	  microglia	  and	  neuroimmune	  signaling	  in	  mice	  in	  order	  to	  create	  a	  molecular	  profile	  for	  this	  animal	  model	  for	  its	  future	  use	  in	  addiction	  studies.	  The	  results	  of	  our	  exploratory	  experiments	  suggest	  that,	  in	  mice,	  morphine	  may	  have	  the	  greatest	  effect	  on	  microglial	  activation	  at	  longer	  time	  points	  (e.g.,	  60	  minutes)	  than	  originally	  demonstrated	  in	  previous	  work	  with	  morphine	  administration	  in	  rats	  [2].	  These	  experiments	  also	  show	  differential	  cytokine/chemokine	  expression	  in	  the	  NAcc	  as	  compared	  to	  the	  HP	  in	  response	  to	  morphine	  administration,	  indicating	  that	  microglia	  may	  behave	  in	  a	  heterogeneous	  manner	  depending	  on	  their	  location	  in	  the	  brain.	  Our	  PCR	  array	  also	  confirms	  some	  of	  the	  results	  achieved	  through	  single	  gene	  real-­‐time	  PCR.	  CCL4	  showed	  a	  significant	  expression	  difference	  in	  both	  the	  single	  gene	  analysis	  and	  PCR	  array,	  with	  increased	  gene	  expression	  visualized	  at	  60	  minutes	  post	  morphine	  injection	  when	  compared	  to	  shorter	  time	  points.	  Other	  significant	  differences	  were	  seen	  in	  CCL7,	  CCR6,	  CMKLR1,	  CXCR7,	  FPR1,	  GPR17,	  Itgb2,	  MAKP14,	  CX3CL1,	  and	  CX3CR1.	  CX3CL1	  and	  CX3CR1	  are	  commonly	  known	  as	  fractalkine,	  a	  neuronal	  chemokine,	  and	  fractalkine	  receptor,	  expressed	  on	  microglia,	  respectively.	  Increases	  in	  neuronal	  fractalkine	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expression	  in	  response	  to	  morphine	  administration,	  mimics	  the	  response	  seen	  in	  rats.	  [2]	  Also,	  several	  trends	  were	  seen	  in	  expression	  levels	  of	  CCL3,	  CCR3,	  CXCL13,	  CXCR3,	  CXCR4,	  Itgam,	  Ppbp,	  and	  TLR4	  with	  respect	  to	  different	  experimental	  time	  points	  in	  the	  NAcc.	  Overall,	  the	  subset	  of	  significant	  chemokine	  expression	  changes	  in	  mice	  differed	  from	  that	  seen	  in	  rats,	  excluding	  neuronal	  fractalkine	  [2],	  suggesting	  that	  chemokine	  response	  profiles	  may	  be	  species	  specific,	  in	  some	  cases.	  In	  light	  of	  our	  laboratory’s	  previous	  findings,	  which	  suggest	  a	  novel	  role	  of	  IL-­‐10	  in	  blocking	  microglial	  activation	  and	  relapse	  in	  rats,	  we	  have	  continued	  to	  investigate	  the	  expression	  of	  IL-­‐10	  in	  mice.	  Though	  it	  is	  not	  clear	  if	  IL-­‐10	  gene	  expression	  differs	  significantly	  in	  the	  NAcc	  and	  HP	  due	  to	  the	  difficult	  nature	  of	  measuring	  IL-­‐10,	  we	  are	  currently	  investigating	  IL-­‐10	  protein	  expression	  through	  an	  Iba-­‐1/IL-­‐10	  immunofluorescent	  IHC	  analysis.	  If	  we	  find	  that	  IL-­‐10	  protein	  expression	  or	  distribution	  is	  significantly	  different	  in	  response	  to	  morphine	  administration,	  this	  may	  suggest	  that	  its	  altered	  expression	  can	  affect	  drug	  addiction	  liability.	  Additionally,	  in	  light	  of	  our	  laboratory’s	  findings	  that	  correlate	  neonatal	  handling	  with	  an	  increase	  in	  IL-­‐10,	  confirmation	  of	  IL-­‐10	  involvement	  in	  drug	  addiction	  in	  mice	  would	  suggest	  that	  early	  life	  experience	  might	  impact	  addiction	  resilience	  in	  adulthood.	  Several	  authors	  have	  implicated	  the	  TLR4	  pathway	  in	  association	  with	  microglial	  activation	  and	  addiction;	  therefore,	  we	  investigated	  whether	  there	  is	  a	  gene	  dose	  response	  of	  TLR4	  on	  learning.	  As	  previously	  mentioned,	  learning	  is	  an	  important	  marker	  for	  ensuring	  proper	  cognitive	  development,	  and	  cognition	  is	  closely	  related	  to	  all	  addiction	  processes.	  We	  use	  the	  well-­‐established	  fear-­‐conditioning	  paradigm	  as	  a	  measure	  of	  cognitive	  viability	  for	  our	  mouse	  model.	  Our	  preliminary	  study	  shows	  that	  female	  HETs	  and	  KOs	  freeze	  considerably	  more	  than	  their	  male	  counterparts.	  In	  addition,	  HETs	  freeze	  significantly	  more	  to	  auditory	  cues	  than	  KOs;	  however,	  increased	  freezing	  in	  female	  HETs	  is	  the	  primary	  driving	  force	  for	  this	  main	  effect.	  In	  addition,	  densitometry	  analysis	  of	  TLR4	  HET	  and	  KO	  brains	  showed	  that	  there	  is	  no	  significant	  difference	  in	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microglia	  density	  or	  distribution	  in	  the	  hippocampus	  with	  respect	  to	  genotype.	  The	  PCR	  array	  results	  show	  a	  trending	  increase	  of	  TLR4	  60	  minutes	  post	  morphine	  injection.	  This	  result	  suggests	  a	  dose	  response	  of	  TLR4,	  which	  mimics	  the	  overall	  increases	  seen	  in	  other	  cytokine/chemokine	  expression	  at	  longer	  time	  points.	  Collectively,	  these	  results	  are	  important	  because	  they	  suggest	  that	  the	  cellular	  profile	  of	  TLR4	  HET	  and	  KO	  mice	  are	  similar;	  however,	  TLR4	  KO	  may	  affect	  learning	  and	  thus	  may	  not	  be	  a	  suitable	  model	  for	  future	  investigation	  of	  TLR4	  involvement	  in	  morphine	  addiction	  acquisition,	  development,	  and	  maintenance.	  A	  microglia-­‐specific	  TLR4	  KO	  may	  be	  a	  potential	  future	  model	  for	  TLR4	  investigation.	  Still,	  caution	  is	  needed	  with	  regard	  to	  behavioral	  models	  of	  addiction	  that	  involve	  learning	  (e.g.,	  CPP).	  There	  are	  still	  several	  questions	  we	  must	  address	  in	  continuing	  this	  microglial	  addiction	  research	  in	  mice.	  First,	  we	  must	  verify	  the	  trends	  that	  we	  have	  seen	  in	  cytokine/chemokine	  expression	  and	  further	  investigate	  the	  relationships	  between	  dosage,	  time	  point,	  and	  gene	  expression.	  Secondly,	  we	  must	  determine	  if	  IL-­‐10	  protein	  expression	  in	  the	  mouse	  brain	  mimics	  the	  same	  pattern	  of	  IL-­‐10	  expression	  previously	  measured	  in	  rats	  [2].	  Answering	  these	  two	  questions	  will	  allow	  us	  to	  more	  confidently	  translate	  our	  previous	  results	  to	  a	  mouse	  model,	  and	  further	  our	  addiction	  research	  through	  the	  use	  of	  transgenic	  mice.	  Microglia	  and	  other	  glial	  cells	  have	  become	  a	  novel	  substrate	  for	  investigation	  in	  the	  field	  of	  addiction	  research,	  yet	  many	  questions	  still	  remained	  unanswered.	  Through	  our	  experiments,	  we	  hope	  to	  elucidate	  the	  time	  course	  of	  microglial	  activity,	  the	  species	  specificity	  of	  microglia	  involvement	  in	  addiction,	  and	  the	  overall	  necessity	  of	  microglial	  activity	  in	  addiction,	  or	  lack	  thereof.	  The	  importance	  of	  these	  experiments,	  collectively,	  stems	  from	  the	  urgent	  need	  to	  understand	  the	  molecular	  profile	  and	  consequences	  of	  drug	  use	  in	  order	  to	  predict	  addiction	  and	  relapse.	  Drug	  addiction	  is	  incredibly	  debilitating	  in	  terms	  of	  socioeconomic	  and	  health	  status	  across	  the	  world.	  Understanding	  the	  molecular	  consequences	  of	  drug	  use	  may	  ameliorate	  the	  difficulty	  of	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drug	  addiction	  treatment	  and	  allow	  us	  to	  more	  effectively	  treat	  addicted	  patients	  and	  prevent	  addiction	  and	  relapse	  in	  vulnerable	  individuals.	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a)	   	   	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  b)	  Figure	  1.	  CCL4	  expression	  shows	  a	  trending	  difference	  between	  the	  5	  and	  60	  minute	  post	  morphine	  injection	  time	  points	  in	  the	  nucleus	  accumbens	  (t(25)=	  -­‐1.83;	  p=0.0792,	  two-­‐tailed),	  but	  not	  in	  the	  HP	  (t(25)=	  -­‐1.06;	  p=	  0.299,	  two-­‐tailed).	  CCL4	  gene	  expression	  in	  the	  nucleus	  accumbens	  and	  hippocampus	  is	  shown	  here	  with	  respect	  to	  time	  and	  morphine	  dose.	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a)	   	  	  b)	  Figure	  2.	  CCL17	  gene	  expression	  was	  significantly	  increased	  in	  the	  HP	  (a)	  compared	  to	  the	  NAcc	  (b)(F(1,93)=	  38.65;	  p<0.001).	  CCL17	  gene	  expression	  in	  the	  hippocampus	  and	  nucleus	  accumbens	  is	  shown	  here	  with	  respect	  to	  time	  and	  morphine	  dose.	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a)	   	  	  	  	  	  	  	  	  	  b)	  Figure	  3.	  CCL25	  gene	  expression	  was	  significantly	  increased	  in	  the	  NAcc	  (a)	  compared	  to	  the	  HP	  (b)(F(1,93)=	  7.20;	  p=	  0.009).	  CCL25	  gene	  expression	  in	  the	  nucleus	  accumbens	  and	  hippocampus	  is	  shown	  here	  with	  respect	  to	  time	  and	  morphine	  dose.	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  Figure	  4.	  IL-­‐10	  gene	  expression	  differed	  between	  5	  and	  40	  minutes	  post	  injection	  time	  points	  in	  HP,	  but	  not	  in	  the	  NAcc	  (t(22)=	  -­‐2.47;	  p=	  0.022).	  IL-­‐10	  gene	  expression	  in	  the	  hippocampus	  is	  shown	  here	  with	  respect	  to	  time	  and	  morphine	  dose.	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  Figure	  5.	  IL-­‐10	  gene	  expression	  differed	  between	  5	  and	  40	  minutes	  post	  injection	  time	  points	  in	  HP,	  but	  not	  in	  the	  NAcc	  (t(22)=	  -­‐2.47;	  p=	  0.022).	  IL-­‐10	  gene	  expression	  in	  the	  nucleus	  accumbens	  is	  shown	  here	  with	  respect	  to	  time	  and	  morphine	  dose.	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  a)	   	  	  
b)	   	   	   	   	   	   	  	  	  	  	  	  	  c)	   	  	  	  	  	  	  	  
d)	   	   	   	   	   	   	  	  	  	  	  	  	  e)	  Figure	  6.	  	  a)	  CCL4	  expression	  in	  the	  NAcc	  shows	  significant	  difference	  between	  the	  20	  min	  and	  60	  min	  post	  injection	  time	  points.	  b)	  CCL8	  expression	  in	  the	  NAcc	  shows	  significant	  difference	  between	  the	  20	  min	  and	  40	  min	  post	  injection	  time	  points.	  c)	  CCR6	  expression	  in	  the	  NAcc	  shows	  significant	  difference	  between	  the	  20	  min	  and	  40	  min	  post	  injection	  time	  points.	  d)	  CMKLR1	  expression	  in	  the	  NAcc	  shows	  significant	  difference	  between	  the	  40	  min	  and	  60	  min	  post	  injection	  time	  points.	  e)	  CXCR7	  expression	  in	  the	  NAcc	  shows	  significant	  difference	  between	  the	  20	  min	  and	  60	  min	  post	  injection	  time	  points.	  Chemokine	  expression	  in	  the	  NAcc.	  	  
Ngan	  Graduation	  with	  Distinction	  thesis	  Department	  of	  Psychology	  and	  Neuroscience	  Bilbo	  lab	  
30	  
a) 	  
b) 	  Figure	  7.	  Increases	  in	  neuronal	  fractalkine	  expression	  in	  the	  NAcc,	  in	  response	  to	  morphine	  administration,	  mimics	  the	  response	  seen	  in	  rats	  [2].	  Neuronal	  fractalkine	  (a)	  and	  neuronal	  fractalkine	  receptor	  (b)	  expression	  in	  the	  NAcc.	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  Figure	  8.	  Contextual	  fear	  conditioning	  differs	  by	  sex,	  with	  females	  freezing	  significantly	  more	  than	  males	  (F(1,19)=	  7.541;	  p=	  0.014).	  Percent	  freezing	  in	  TLR4	  HET	  and	  KO	  mice	  is	  shown	  here	  in	  response	  to	  a	  contextual	  fear-­‐conditioning	  paradigm.	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  Figure	  9.	  Percent	  freezing	  during	  conditioned	  stimulus	  conditioning	  (auditory-­‐cued)	  shows	  a	  difference	  by	  genotype	  with	  KOs	  freezing	  significantly	  less	  than	  their	  HET	  counterparts	  (F(1,19)=	  6.06;	  p=	  0.026).	  Percent	  freezing	  in	  TLR4	  HET	  and	  KO	  mice	  is	  shown	  here	  in	  response	  to	  auditory	  fear	  conditioning	  paradigm.	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